Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Inflammatory Bowel Disease
•
Gastroenterology
When do you consider de-escalation from combination therapy with anti-TNFs and thiopurines to monotherapy with anti-TNFs in patients with IBD?
Answer from: at Academic Institution
I withdraw the thiopurine if after 1 year the patient has achieved the goals of care.
Sign in or Register to read more
25838
Related Questions
What diet do you recommend for patients with inflammatory bowel disease?
Would you start a biologic without a tissue diagnosis in a young male presenting with recurrent small bowel obstruction and MRE showing distal ileitis, which was unable to be reached despite repeat colonoscopy?
What is your approach to managing ILD associated with inflammatory bowel disease?
In patients with longstanding UC or Crohn's colitis, would you extend the interval of surveillance colonoscopy to longer than 3 years if they have had little inflammatory disease over the years and no other factors to increase their risk (ie, history of polyps, history of dysplasia, or family history)?
How would you manage a patient with Crohn's disease on a biologic and presents with non-bloody diarrhea, normal-appearing mucosa on sigmoidoscopy but severe colitis on biopsy with a positive CMV stain?
How do you incorporate intestinal ultrasound in the care of patients with inflammatory bowel disease?
What is your advice to patients with IBD who are on biologic therapies and planning for pregnancy?
What are your vaccine recommendations while patients are on biologics?
How do you approach the treatment of Crohn's colitis in the setting of immunosuppression for liver transplant?
What techniques do you find most effective for visualization of rectal disease with intestinal ultrasound?